BSE filing, NSE: SAMBHV. Summary written from the filing by ALFA Finder's alert engine.
Sambhv Steel Tubes Ltd: key numbers
- Share price
- ₹166.45
- Market cap
- ₹4,905 Cr
- Revenue (annual)
- ₹2,413 Cr
- Net profit (annual)
- ₹142.2 Cr
- P/E (TTM)
- 29.8×Sector 16.9×
- Promoter holding
- 56.11%+0.00% QoQ
- FII holding
- 1.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sambhv Steel Tubes Ltd
All →Sambhv Steel Tubes Board Meeting Date
Sambhv Steel Tubes will hold a board meeting on 29 October 2026 to consider unaudited quarterly results for September 2026. The trading window stays closed until 31 October 2026.
Sambhv Steel Tubes Convertible Warrants
Sambhv Steel Tubes Limited allotted 8,695,400 convertible equity warrants at ₹115 per warrant, aggregating to ₹99.9971 Crore, on a preferential basis.
- Value
- ₹100.00 Cr
- Execution
- 18 months
Sambhv Steel Tubes Capital Structure Change
Sambhv Steel Tubes appointed CARE Ratings as a monitoring agency for its preferential warrant issue. The issue proceeds amount to Rs. 99.9971 Crore.
- Value
- ₹100.00 Cr
Sambhv Steel Tubes Business Update
Sambhv Steel Tubes reported its Q2 FY27 sales volume update, showcasing growth in its Structural Pipes and Tubes and Pre-Galvanized Coils and Pipes segments.
Sambhv Steel Tubes Capital Structure Change
Sambhv Steel Tubes clarifies regulatory compliance and VWAP calculations for its proposed preferential issue of 8,695,400 fully convertible equity warrants at ₹115 each.
- Value
- ₹100.00 Cr
Sambhv Steel Tubes Annual General Meeting
Sambhv Steel Tubes Limited held its 9th Annual General Meeting on September 10, 2026, transacting business items including adoption of financial statements and director reappointment.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.